Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$3.74 USD
-0.23 (-5.79%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.74 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVAH 3.74 -0.23(-5.79%)
Will AVAH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health to Expand Florida Presence With New 50-bed Facility
Other News for AVAH
Aveanna Healthcare Holdings Improving Performance In High-Demand Sector
This Keysight Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
Jefferies Upgrades Aveanna Healthcare (AVAH) Despite Lowered Price Target | AVAH Stock News
Aveanna (AVAH) Receives Upgrade from Jefferies, Boosting Investor Confidence | AVAH Stock News
Aveanna just upgraded at Jefferies, here's why